Vibliome

Bozeman, United States

Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.

$38.0M raised

Feb 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vibliome raised?

Vibliome has raised $38.0M in total funding. The most recent round was Series A. The last funding was announced in February 2022.

Who are Vibliome's investors?

Vibliome's investors include Deerfield.

Where is Vibliome headquartered?

Vibliome is headquartered in Bozeman, United States.

What does Vibliome do?

Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.

What stage is Vibliome at?

Vibliome is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 24, 2022.

MLA

"Vibliome — Funding & Investors." VCBacked, February 24, 2022, https://www.vcbacked.co/company/vibliome. Accessed July 2, 2026.

APA

VCBacked. (2022). Vibliome — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vibliome

Wikipedia (cite web)

{{cite web |title=Vibliome — Funding & Investors |url=https://www.vcbacked.co/company/vibliome |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 24, 2022.